Erratum : Rates and determinates of 5-year outcomes after atrial fibrillation-related stroke: A population study (Stroke (2015), 46 (3488-3493) DOI: 10.1161/STROKEAHA.115.011139);Rates and determinants of 5-year outcomes after atrial fibrillation-related stroke: A population study

Stroke

Volumn 46, Issue 12, 2015, Pages 3488-3493

  Hayden, Derek T ^a   Hannon, Niamh ^d   Callaly, Elizabeth ^a,c   Ní Chróinín, Danielle ^a   Horgan, Gillian ^a   Kyne, Lorraine ^a   Duggan, Joseph ^a   Dolan, Eamon ^c   O'Rourke, Killian ^b   Williams, David ^e   Murphy, Sean ^a,e   Kelly, Peter J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c Stroke and Hypertension Unit   (Ireland)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

atrial fibrillation; nursing homes; rehabilitation; stroke; survival

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING HOME; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; RANKIN SCALE; SECONDARY PREVENTION; STROKE PATIENT; SUBARACHNOID HEMORRHAGE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; COMPLICATION; EPIDEMIOLOGY; HEALTH SURVEY; IRELAND; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR; STROKE; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRELAND; MALE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84948072281     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STR.0000000000000088     Document Type: Erratum

References (26)

1. Heuschmann PU, Di Carlo A, Bejot Y, Rastenyte D, Ryglewicz D, Sarti C, Incidence of stroke in europe at the beginning of the 21st century. Stroke 2009 40 1557 1563. doi: 10.1161/STROKEAHA.108.535088.
2. Kelly PJ, Crispino G, Sheehan O, Kelly L, Marnane M, Merwick A, Incidence, event rates, and early outcome of stroke in Dublin, Ireland: the North Dublin population stroke study. Stroke 2012 43 2042 2047. doi: 10.1161/STROKEAHA.111.645721.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001 285 2370 2375
4. Yiin GS, Howard DP, Paul NL, Li L, Luengo-Fernandez R, Bull LM, Oxford Vascular Study Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study. Circulation 2014 130 1236 1244. doi: 10.1161/CIRCULATIONAHA.114.010942.
5. Kelly PJ., Preventing the rise of atrial fibrillation-related stroke in populations: a call to action. Circulation 2014 130 1221 1222. doi: 10.1161/CIRCULATIONAHA.114.012738.
6. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005 36 1115 1119. doi: 10.1161/01.STR.0000166053.83476.4a.
7. Hannon N, Sheehan O, Kelly L, Marnane M, Merwick A, Moore A, Stroke associated with atrial fibrillation-incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis 2010 29 43 49. doi: 10.1159/000255973.
8. Candelise L, Pinardi G, Morabito A., Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group. Stroke 1991 22 169 174
9. Hannon N, Daly L, Murphy S, Smith S, Hayden D, Ní Chróinín D, Acute hospital, community, and indirect costs of stroke associated with atrial fibrillation: population-based study. Stroke 2014 45 3670 3674. doi: 10.1161/STROKEAHA.114.005960.
10. Central statistics office Ireland Census of Population of Ireland 2006 2007 Volumes 1 and 2 Dublin Stationery office
11. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, ACC/AHA Task Force Members 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014 130 e199 e267. doi: 10.1161/CIR.0000000000000041.
12. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, CONCORD Working Group Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008 9 730 756. doi: 10.1016/S1470-2045(08)70179-7.
13. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996 27 1760 1764
14. Sandercock P, Bamford J, Dennis M, Burn J, Slattery J, Jones L, Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). BMJ 1992 305 1460 1465
15. 2-VASc, and long-Derm stroke outcome in patients without atrial fibrillation. Neurology 2013 80 1009 1017. doi: 10.1212/WNL.0b013e318287281b.
16. Henriksson KM, Farahmand B, Johansson S, Asberg S, Terént A, Edvardsson N., Survival after stroke-Dhe impact of CHADS2 score and atrial fibrillation. Int J Cardiol 2010 141 18 23. doi: 10.1016/j.ijcard.2008.11.122.
17. Hong HJ, Kim YD, Cha MJ, Kim J, Lee DH, Lee HS, Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation. Eur J Neurol 2012 19 284 290. doi: 10.1111/j.1468-1331.2011.03518.x.
18. Tanaka K, Yamada T, Torii T, Furuta K, Matsumoto S, Yoshimura T, Pre-Admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation. J Stroke Cerebrovasc Dis 2015 24 1629 1635. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.036.
19. Hannon N, Callaly E, Moore A, Ní Chróinín D, Sheehan O, Marnane M, Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study. Stroke 2011 42 2503 2508. doi: 10.1161/STROKEAHA.110.602235.
20. O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, Bradley C, Investigators of the Registry of the Canadian Stroke Network Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol 2006 5 749 754. doi: 10.1016/S1474-4422(06)70536-1.
21. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY., Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010 123 638 645.e4. doi: 10.1016/j.amjmed.2009.11.025.
22. Scowcroft AC, Lee S, Mant J., Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009. Heart 2013 99 127 132. doi: 10.1136/heartjnl-2012-302843.
23. Hart RG, Pearce LA, Aguilar MI., Meta-Analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007 146 857 867
24. Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP., Risk and cumulative risk of stroke recurrence: a systematic review and meta-Analysis. Stroke 2011 42 1489 1494. doi: 10.1161/STROKEAHA.110.602615.
25. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO., Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 2000 31 1062 1068
26. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL., Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000 35 183 187